Combination therapies for treating metastatic melanoma
Tawbi, H.; Tawbi, H.
Clinical Advances in Hematology and Oncology H&o 13(4): 211-214
2015
ISSN/ISBN: 1543-0790 PMID: 26352577 Document Number: 684550
Document emailed within 1 workday
Related Documents
Chouake, J.; Friedman, A. 2012: Novel therapies for the treatment of metastatic melanoma Journal of Drugs in Dermatology: Jdd 11(2): 271-273Claveau, J.; Ho, V.; Petrella, T. 2014: Metastatic melanoma: optimizing outcomes by managing dermatologic toxicities associated with novel therapies Skin Therapy Letter 19(2): 1-4
Garbe, C.; Zouboulis, C.C.; Krüger, S.; Waibel, M.; Kreuser, E.D.; Stadler, R.; Orfanos, C.E. 1992: Combination of interferon-alpha with cytostatic drugs: a potentially successful therapeutic approach in metastatic melanoma Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 43(1): 4-10
Legha, S.S. 1997: Durable complete responses in metastatic melanoma treated with interleukin-2 in combination with interferon alpha and chemotherapy Seminars in Oncology 24(1 Suppl 4: S39-S43
Gundersen, S.; Hager, B.; Tausjø, J. 1986: Radiation in combination with intra-arterial infusion therapy with dacarbazine for metastatic malignant melanoma localized to a lower extremity Cancer Treatment Reports 70(8): 1015-1017
Sonoo, H.; Senoo, T.; Nishiki, M.; Morimoto, T.; Takashima, S. 1996: Effectiveness of combination hormonal therapies in advanced or recurrent breast cancer--a randomized trial of tamoxifen (TAM), medroxyprogesterone acetate (MPA), their simultaneous combination, and an alternating sequential combination of TAM plus MPA Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(4): 447-454
Spiro, T.; Liu, L.; Gerson, S. 2000: New cytotoxic agents for the treatment of metastatic malignant melanoma: temozolomide and related alkylating agents in combination with guanine analogues to abrogate drug resistance Forum 10(3): 274-285
Dutcher, J.P. 2011: High-dose interleukin-2 therapy for metastatic renal cell carcinoma and metastatic melanoma: still the standard Oncology 25(5): 427-428
Saha, S.; Mohanty, K.C. 2003: Enhancement of metastatic potential of mouse B16-melanoma cells to lung after treatment with gangliosides of B-16-melanoma cells of higher metastatic potential to lung Indian Journal of Experimental Biology 41(11): 1253-1258
Frydland, M.; Elming, H.; Ahlehoff, O. 2014: Malignant melanoma with metastatic melanoma to the heart Ugeskrift for Laeger 176(25)
Skowronek, J.; Roszak, A. 1997: A case of metastatic malignant melanoma of the vagina with a background of primary vaginal melanoma--clinical case Ginekologia Polska 68(8): 390-393
van Groningen, J.J.; Bloemers, H.P.; Swart, G.W. 1995: Identification of melanoma inhibitory activity and other differentially expressed messenger RNAs in human melanoma cell lines with different metastatic capacity by messenger RNA differential display Cancer Research 55(24): 6237-6243
Hung, H.-M.; Chen, C.-H. 2011: Using alternative therapies in treating sleep disturbance Hu Li Za Zhi Journal of Nursing 58(1): 73-78
Jacquard, J. 2009: Psycho-educative therapies for treating bipolar patients Revue de l'Infirmiere 149: 24-26
Sherer, Y.; Shoenfeld, Y. 1997: Tumor metastases--new experimental anti-metastatic therapies Harefuah 133(12): 636-641
Calgüneri, M.; Cobankara, V.; Oztürk, M.A.; Ertenli, I.; Kiraz, S.; Apraş, S. 2004: Combination therapies in spondyloarthropathies Kobe Journal of Medical Sciences 50(1-2): 31-37
Takeshita, A.; Ohno, R. 2000: New combination therapies in hematological malignancies Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(3): 388-394
Moro-Sibilot, D.; Coudurier, M. 2009: Targeted therapies in second line treatment of metastatic non-small cell lung cancer La Revue du Praticien 59(7): 955-956
Lencioni, R.; Cioni, D.; Donati, F.; Bartolozzi, C. 2001: Combination of interventional therapies in hepatocellular carcinoma Hepato-Gastroenterology 48(37): 8-14
Farlow, M.R. 2005: Combination drug therapies for AD: progress is slow, but we must keep trying Geriatrics 60(6): 13-14